DRL logo

Matched Pair: Cancer-Associated + Tumor-Adjacent Normal Fibroblasts, same donor – Prostate

Disease-vs-normal fibroblast pair from a single donor: cancer-associated fibroblasts plus tumor-adjacent normal fibroblasts. Removes donor-to-donor variation from CAF activation studies. Research use only.

$2,800

per vial, USD
Out of stockShips in 3 weeks, derived from banked material· Ship as Vials on dry ice· BSL-2Max per order: 3

Out of stock

Detailed description
Specifications
Biological characteristics
Tumor type Prostate Adenocarcinoma
Species Homo sapiens, human
Tissue source Tumor + adjacent normal tissue, same donor
Post-thaw viability (guaranteed min %) > 80%
Cells per vial > 1 x 10^6 cells
Culture & handling
Freezing medium CryoStor/FBS+DMSO
Medium kit available? Yes
Storage on arrival LN Vapor
Ships as Vials on dry ice
Biosafety level BSL-2
Quality control & documentation
Donor clinical metadata provided Yes
Marker panel Biomarker-authenticated
Mycoplasma test Yes
Certificate of Analysis (CoA) Included
Compliance
Intended use This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
Consent covers commercial sale of derived cells? Yes – IRB-approved
ready to ACCELerate your program?
Need same-donor materials or a custom model?
Tell us your indication and model type — our scientists will match the right DRL product.
DRL logo
Contract research organization, which provides solutions for pharma and diagnostics companies, including consulting, cancer models development, and various assays for drug development.
contact
28047 Dorothy Drive, #204,
Agoura Hills, CA 91301, USA
Call: +1 442-224-3375
E-mail: Info@drlus.com
©2026 DRL US. All Rights Reserved.